16 May 2025
Drug Utilisation Sub-Committee (DUSC) Outcome Statement 16 May
Drug Utilisation Sub-Committee (DUSC) Outcome Statement
02 May 2025
Update to Agenda for the May 2025 PBAC Meeting
Update to Agenda for the May 2025 PBAC Meeting
24 Apr 2025
PBAC Public Summary Documents (first time decisions not to recommend and deferrals) – December 2024 meeting
PBAC Public Summary Documents (first time decisions not to recommend and deferrals) – December 2024 meeting
24 Apr 2025
Recommendations made by the Pharmaceutical Benefits Advisory Committee (PBAC) – March 2025
Recommendations made by the Pharmaceutical Benefits Advisory Committee (PBAC) – March 2025
17 Apr 2025
Pharmaceutical Benefits Scheme (PBS) Safety Net Threshold changes
Pharmaceutical Benefits Scheme (PBS) Safety Net Threshold changes
14 Apr 2025
New Online Portal & Info Sheet: Stay Compliant with Minimum Stockholding Requirements
New Online Portal & Info Sheet: Stay Compliant with Minimum Stockholding Requirements
09 Apr 2025
New Minimum Stockholding Requirements Online Notification Portal and Fact Sheet
New Minimum Stockholding Requirements Online Notification Portal and Fact Sheet
01 Apr 2025
Expanded access to empagliflozin for type 2 diabetes patients with high cardiovascular risk
Expanded access to empagliflozin for type 2 diabetes patients with high cardiovascular risk
